HELP     Sign In

Xp21.3-p21.1CNV Type: Deletion


Largest CNV size: 4594899 bp

Statistics Box:
Number of Reports: 2



Summary Information

A de novo Xp21.3-p21.1 deletion was identified in an ASD proband from the Autism Simplex Collection (Yuen et al., 2017).

Additional Locus Information

Genome browsers

USCS Symbol             NCBI Symbol

Decipher

            Decipher Symbol

References

Major Reports

Title
Author, Year
Report Class
CNV Type
Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder
Deletion

Minor Reports

Title
Author, Year
Report Class
CNV Type
NA
Deletion

Cases

Cohort ID
Author, Year
Descripton
Cohort Size
Diagnosis
Age
Gender
CNV Size
Deletion
Duplication
Total CNV's
 mazzonetto_24_ASD/DD/ID_discovery_cases
  NA NA
 Patients from a total of 15 non-profit organizations and university centers located in different states of Brazil who were enrolled between July 2021 and June 2022 and referred with unexplained neurodevelopmental delay/intellectual disability, autism spectrum disorder (ASD), and/or multiple congenital anomalies.
 1363
 "95% of individuals in this cohort reported with the HPO phenotype ""Abnormality of the nervous system"" (HP:0000707); the HPO phenotypes ""Intellectual disability"" (HP:0001249; 36%), ""Global developmental delay"" (HP:0001263; 32%), and ""Autism"" (HP:0000717; 28%) were the most frequently reported phenotype subcategories within this subset of individuals."
 
 63.17% Male
 4262832
 1
 0
 1
 yuen_17_ASD_discovery_cases
 ASD genomes (1745 ASD probands, 879 ASD-affected siblings, 1 ASD-affected father, and 1 ASD-affected grandfather) from AGRE (n=730), the AGRE; Autism Treatment Network cohort (n=192) ,the ASD: Genomes to Outcomes Study cohort (n=1421), the Baby Siblings Research Consortium (n=43), the Baby Siblings Research Consortium; The Autism Simplex Collection cohort (n=6), the Infant Sibling Study (n=62), th
 2626
 ASD diagnosis of research quality when meeting criteria on one (n=437) or both (n=1361) of the diagnostic measures ADI-R and ADOS; clinical diagnosis of ASD (n=819) when given by expert clinician according to DSM-IV or DSM-5
 N/A
 78.71% Male
 4594899
 1
 0
 1

Controls

No Control Data Available

Cases

Cohort ID
Geographical Ancestry
Discovery Method
Platform
Algorithm
Software
Validation Method
 mazzonetto_24_ASD/DD/ID_discovery_cases
  Brazil
 Low-pass WGS
  Illumina NovaSeq 6000
 SNP-FASST2 (HMM)
 BioDiscovery NxClinical
 
 yuen_17_ASD_discovery_cases
  N/A
 WGS
  Complete Genomics, Illumina HiSeq 2000, HiSeq X
 
 
 aCGH (Agilent 1M), array SNP (Affymetrix 6.0, Affymetrix CytoScan HD), solid phase hybridization (Illumina 1M, Illumina OMNI 2.5M)

Controls

No Control Data Available

Cases

Patient ID
Author, Year
Age
Gender
Primary Diagnosis
Clinical Profile
Cognitive Profile
CNV Start
CNV End
CNV Size
Genome Build
Type Method
Validation
  mazzonetto_24_ASD/DD/ID_discovery_cases-caseDECIPHER530663
  NA NA
 
 M
 
 No phenotypic information provided
 
 28782911
 33045742
  4262832
 GRCh38
 Deletion
 No
  yuen_17_ASD_discovery_cases-case1-0487-003
 N/A
 N/A
 ASD
 Case cohort: The Autism Simplex Collection . Clinical description: N/A
 
 27170484
 31765383
  4594900
 GRCh38
 Deletion
 Yes

Controls

No Control Data Available

Cases

Patient ID
Validation Description
Primary Disorder Inheritence
Inheritence
Family Profile
Disease Segregation
Gene Content
Altered Gene Expression
 mazzonetto_24_ASD/DD/ID_discovery_cases-caseDECIPHER530663
 
 
 Unknown
 
 
 NR0B1,DMD,FTHL17,TASL,GK,TAB3,FTLP2,TBCAP1,CKS1BP6,TAB3-AS1,PIGFP3,NPM1P8,MAGEB4,MAGEB3,MAGEB2,MAGEB1,MIR548F5,PLCE1P1,MIR3915,RNA5SP500,MIR4666B,RNA5SP501,GK-AS1,DMD-AS3,TAB3-AS2,GK-IT1,RNU6-894P,IL1RAPL1
 
 yuen_17_ASD_discovery_cases-case1-0487-003
 Affymetrix 6.0
 
 De novo
 Simplex
 Segregated
 PTP4A1P5,PPP4R3C,DCAF8L1,MIR6134,RNA5SP500,MIR4666B,PIGFP3,MAGEB2,MAGEB3,MAGEB4,PLCE1P1,NR0B1,CKS1BP6,FTLP2,GK-IT1,TAB3-AS2,FTHL17,RNU6-894P,MAGEB10,MAGEB1,CXorf21,GK-AS1,TAB3-AS1,DCAF8L2,GK,TAB3,IL1RAPL1,DMD
 

Controls

No Control Data Available
No Animal Model Data Available
HELP
Copyright © 2017 MindSpec, Inc.